MRI and PET to Assess Pembrolizumab Response

Clinical trial NCT02591654 · TERMINATED

Trial details

NCT number: NCT02591654
Sponsor: Columbia University
Status: TERMINATED
Phase: Early Phase 1
Study type: INTERVENTIONAL

Malignant Melanoma, Metastatic

Start date: 2015-10-01
Primary completion: 2022-10-01
Enrollment: 6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.